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G protein-coupled receptor 116 (GPR116) is a novel member of the G protein-coupled receptors and
its function is largely unknown. To investigate the physiological function of GPR116 in vivo, we gen-
erated adipose tissue speciﬁc conditional Gpr116 knockout mice (CKO) and fed them on standard
chow or high fat diets. Selective deletion of Gpr116 in adipose tissue caused a pronounced glucose
intolerance and insulin resistance in mice, especially when challenged with a high fat diet. Biochem-
ical analysis revealed a more severe hepatosteatosis in CKO mice. Additionally, we found that CKO
mice showed a lowered concentration of circulating adiponectin and an increased level of serum
resistin. Our study suggests that GPR116 may play a critical role in controlling adipocyte biology
and systemic energy homeostasis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Adipose tissue is traditionally regarded as an inert organ for
storage of excess energy in the form of triacylglycerol (TG).
However, this notion has been challenged by the ﬁndings during
the past two decades. Adipose tissue is now well regarded as a
highly complex and dynamic endocrine organ since it secretes a pa-
nel of lipid derivatives and bioactive peptides, termed ‘adipokines’,
and thereby serves as a master regulator in maintaining systemic
energy homeostasis [1]. Adipose dysfunction, characterized by an
abnormal expression of adipokines [2] and the presence of a
low-grade, chronic inﬂammation [3,4], are closely associated with
obesity related diseases [5]. While in much rare cases, pathological
conditions characterized by an abnormal distribution of adipose
tissues, such as lipohypertrophy or lipodystrophy, are also accom-
panied by themalfunctioning of adipose tissue. Increasing evidence
suggests that adipose tissue dysfunction plays a prominent role in
the development and progression of metabolic disorders including
insulin resistance, type 2 diabetes and cardiovascular diseases [5].chemical Societies. Published by E
ang), wu_donghai@gibh.ac.cnTherefore, identiﬁcation of key factors that control the physiology
of adipose tissuewould lead to new therapeutic approaches for pre-
vention and treatment of metabolic related diseases.
G protein-coupled receptors (GPCRs) constitute one of the larg-
est families of cell-surface receptors and are estimated to be en-
coded by more than 1000 genes in human genome [6]. They
share a characteristic structure of seven transmembrane a helices
with an extracellular N terminus and a cytoplasmic C terminus.
GPCRs convert extracellular messages into intracellular responses
and are involved in essentially every aspect of cellular functions.
Notably, more than 50% of all prescription drugs on the market di-
rectly or indirectly target GPCRs [7]. While GPCR targeted medi-
cines are used to treat a broad spectrum of diseases ranging from
cancer, cardiovascular diseases, to Alzheimer’s disease as well as
many other diseases, the application of GPCR targeted medicine
in metabolic disease interventions is minimal.
Recently a few GPCRs have been implicated in the development
of metabolic diseases. GPR40, which is selectively expressed in
pancreatic b cells, is required for free fatty acid evoked insulin
secretion [8]. GPR43 and GPR120 are abundantly present in adipose
tissues and they were found to enhance adipogenesis in 3T3-L1
adipocytes [9,10]. The rhodopsin family member GPR120 has been
shown to function as an x-3 fatty acid (x-3 FA) receptor/sensor tolsevier B.V. All rights reserved.
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beneﬁcial effects of x-3 FA treatment were abrogated in GPR120
knockout mice. In addition, GPR120 promotes secretion of GLP-1
and increases circulating levels of insulin [12].
GPR116 belongs to the LNB-TM7 subfamily of GPCRs. This pro-
tein is known to be highly expressed in lung and can be processed
into four fragments, namely, presequence, proEGF2 (a fragment),
Ig repeats (b chain), and TM7 (c chain) [13]. The natural ligand(s)
and physiological role of GPR116 remain elusive. We found that
GPR116 is also present in adipocyte cell lines and mouse adipose
tissue, suggesting that this protein might be a modulator of
adipose tissue function. Therefore, in the current study, we inves-
tigated the potential role of this protein in adipocytes using both
in vitro and in vivo based approaches.2. Materials and methods
2.1. Differentiation of 3T3-L1 adipocyts and oil red O staining
Mouse 3T3-L1 preadipocytes were normally cultured in Dul-
becco’s modiﬁed Eagle’s medium (DMEM, GIBCO) with 10% fetal
bovine serum (FBS, Hyclone). Two days after reaching conﬂuence
(day 0), the cells were subjected to adipogenic differentiation in
differentiation medium containing 5 lg/ml insulin (Sigma), 1 lM
dexamethasone (Sigma), and 0.5 mM isobutylmethylxanthine (Cal-
biochem). Two days later the medium was replaced with DMEM
supplemented with 10% FBS and 5 lg/ml insulin for additional
two days before changed to the normal medium until day 8.
For oil red O staining, 3T3-L1 adipocytes were ﬁxed in 10% for-
malin for 5 min, followed by incubation in fresh formalin for 1 h
before washed brieﬂy with 60% isopropanol and stained for
10 min in freshly prepared 60% oil red O solution. For quantitative
analysis, oil red O was eluted with 100% isopropanol and its optical
density was measured at 500 nm in a spectrophotometer (Beck-
man Coulter).
2.2. Isolation of adipocytes and stromal-vascular cells from adipose
tissues
Isolation of mature adipocytes and stromal cells from fat tissue
was performed as previously described [14]. Epidydimal adipose
tissue was dissected out, rinsed in phosphate-buffered saline
(PBS), minced, and digested for 40 min at 37 C in 0.1% (w/v) colla-
genase solution (Collagenase type I, dissolved in D-Hanks buffer).
The digested tissue was ﬁltered through a 250 lm nylon mesh to
remove undigested tissues before centrifuged at 800g for 3 min.
The ﬂoating layer (adipocytes) and the pellet (strormal cells) were
collected and washed again in PBS.
2.3. siRNA transfection
SiRNA oligonucleotides were synthesized and purchased from
Guangzhou RiboBio Company. Transfection of siRNA into the
3T3-L1 cells was performed with Lipofectamine2000 (Invitrogen)
according to the manufacturer’s instructions. The transfected cells
were subjected to standard differentiation as described above.
2.4. Generation of adipose-speciﬁc Gpr116 knockout mice
Gpr116ﬂox/ﬂox mice and aP2 (Fabp4)-Cre transgenic mice were
crossed to produce the adipose speciﬁc Gpr116 conditional knock-
out mice, Gpr116ﬂox/ﬂox and aP2-Cre positive (Gpr116ad/).
Gpr116ﬂox/ﬂox mice were used as the control. Primers used for
Gpr116ﬂox/ﬂox genotyping are: GCGACCCACAGGTTGAGAAC as the
forward primer (GF) and GTCACCGCCCTAACATTTGC as the reverseprimer (GR) while these for Cre genotyping are AGCGATG-
GATTTCCGTCTCTGG (CF) and AGCTTG CATGATCTCCGGTATTGAA
(CR).
2.5. Total RNA extraction and quantitative PCR
Total RNA was isolated from cells and tissues using Trizol Re-
agent (Invitrogen). First-strand cDNA synthesis was performed
with Superscript™ III Reverse Transcriptase (Invitrogen). Quantiﬁ-
cation of mRNA levels was performed using SYBR

Premix Ex Taq™
(TaKaRa) under optimized conditions following the manufacturer’s
instruction. The reference gene chosen was 18S ribosomal RNA. The
primers were synthesized by Invitrogen in Shanghai, China. The
sequences of the primers are listed in Supplementary Table 1.
2.6. Antibody production
Polyclonal antibody against GPR116 was raised in rabbits
immunized with the peptide YKTDLERAFRAGYRT coupled with
keyhole limpet haemocyanin.
2.7. Standard chow and high fat diet (HFD) feeding
Male mice [8-week-old, 129Sv (50%)/C57BL/6J (50%)] were
housed in metabolism cages and maintained on a 12 h light–dark
cycle at 23 C and fed standard chow diet (SCD) (15.9 kJ/g, 10% of
energy as fat, 20% of energy as protein, 70% of energy as carbohy-
drate; GB14924; Guangdong Medical Laboratory Animal Center,
Guangzhou, China) or high fat diet (HFD) (21.9 kJ/g, 60% of energy
as fat, 20% of energy as protein, 20% of energy as carbohydrate;
D12492; Research Diet, New Brunswick, NJ, USA). Food intake
was measured daily and body weight was measured weekly. All
experiments with animals were approved by the Animal Care
and Use Committee of Guangzhou Institute of Biomedicine and
Health, Chinese Academy of Sciences.
2.8. Glucose and insulin tolerance test
For glucose tolerance test, mice were fasted overnight and in-
jected intraperitoneally (i.p.) with 20% glucose at a dose of 2 g/kg
body weight. For insulin tolerance test, mice were starved for 6 h
and i.p. injected with 0.5 U/kg body weight recombinant human
insulin (Eli Lilly). Blood glucose was monitored from the tail vein
blood using a glucometer (ACCU-CHEK Advantage; Roche Diagnos-
tics China, Shanghai, China) at various time points.
2.9. Analysis of plasma constituents
Blood samples were collected from cut tail tips of conscious
overnight-fasted mice. Plasma triacylglycerol and cholesterol were
measured using commercial kits (Triacylglycerol Kit and Choles-
terol Kit; Proteomics analysis Jiancheng, Nanjing, China). Plasma
adiponectin was measured by an ELISA kit (Millipore). Plasma res-
istin was measured by an ELISA kit (Raybiotech). Plasma levels of
TNF-a and IL-1b were measured by ELISA kits (R&D).
2.10. Extraction and quantiﬁcation of lipids
Tissues were homogenized in 2:1 chloroform/methanol solu-
tion in a 20:1 (20 ml/1 g) volume-to-weight ratio and incubated
at room temperature for 6 h with gentle shaking. After that,
H2SO4 (1 mM) was then added, centrifuged at the maximal speed
for 15 min and the organic bottom layer was collected. The organic
solvent was dried and the extracted lipids were re-dissolved in
50 ll ethanol. Triacylglycerol content was measured by the same
Triacylglycerol Kit as mentioned above.
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White adipose tissues were ﬁxed in 4% formaldehyde overnight
at room temperature immediately after the mice were sacriﬁzed.
Tissues were parafﬁnized and sectioned by microtome, and the
slides were stained with hematoxilin and eosin (H&E) (Sigma) fol-
lowing the standard protocol. Sections were examined by light
microscopy. Photomicrographs were scanned using an Abaton Scan
300/Color scanner. The digitized images were analyzed on a PC
computer using the UTHSCSA ImageTool program (http://
www.ddsdx.uthscsa.edu/dig/itdesc.html). Parafﬁn embedded sec-
tions of adipose tissues were stained with anti-rabbit F4/80
(1:100; Abcam; ab100790) to assess macrophage inﬁltration.
2.12. Statistical analysis
Data are expressed as means ± SEM. All comparisons were ana-
lyzed by unpaired, two-tailed Student’s t-test. A p value of p < 0.05
was considered signiﬁcant.
3. Results
3.1. GPR116 is required for differentiation of 3T3-L1 preadipocytes
The mRNA of Gpr116 was detected in mouse adipose tissue by
RT-PCR (data not shown). To further verify this ﬁnding, we isolated
mature adipocytes and stromal vascular fraction frommouse white
adipose tissue and the expression of Gpr116 in these two cell types
was examined by qRT-PCR. The results demonstrated that Gpr116
mRNAwas abundantly present in bothmature adipocytes and stro-
mal vascular fractions, at a level comparable to some of the known
adipogenic markers such as peroxisome proliferator activator
receptor-c (PPARc) and adipocyte fatty acid-binding protein (aP2/
FABP4) (Fig. 1A). The expression proﬁle of Gpr116 was also investi-
gated in 3T3-L1 cells. Interestingly, we found that the expression
level of Gpr116 was gradually and signiﬁcantly increased during
the ﬁrst 6 days of differentiation but came back down at day 8
(Fig. 1B and G). This expression pattern is largely reminiscent to
that of PPARc, which plays a key role in adipocyte differentiation.
The above mentioned ﬁndings suggest that GPR116 might play a
potentially critical role in adipocyte physiology.
To further investigate the role of GPR116 in adipocyte differen-
tiation, we reduced Gpr116 expression in 3T3-L1 cells by siRNA
mediated knockdown (Fig. 1C). Compared to the cells transfected
with scrambled siRNA, the efﬁciency of adipocyte differentiation
was remarkably diminished in 3T3-L1 adipocytes with speciﬁc
knockdown of Gpr116, as evidenced by a decreased level of PPARc
and aP2 (Fig. 1C). The impairment in adipocyte differentiation was
further corroborated by oil red O staining and TG quantiﬁcation
(Fig. 1D and 1F). This result suggests that GPR116 is required for
the in vitro adipogenesis of 3T3-L1 adipocytes. Since PPARc2 was
one of the most important regulators of preadipocyte differentia-
tion, we wanted to determine whether up-regulation of PPARc2
has any effect on the expression of Gpr116 mRNA. 3T3-L1 cells
were treated by rosiglitazone, a known PPARc agonist, during the
process of adipocyte differentiation and the treatment increased
Gpr116 mRNA levels further on day 6 and day 8 (Fig. 1H). In addi-
tion, transient transfection of pCMV driven human cDNA encoding
GPR116 enhanced adipogenic differentiation in 3T3-L1 cells (Sup-
plementary Fig. 1).
3.2. Generation of adipose tissue speciﬁc Gpr116 knockout mice
Next we sought to investigate the physiological role of GPR116
in adipose tissue in vivo. To this end, we generated adipose speciﬁc
knockout mice of Gpr116 (CKO) as described in Session 2 (Fig. 2A).The Gpr116ﬂox/ﬂox littermates were used as the wild type control
(WT). The adipose selective deletion of Gpr116 was conﬁrmed by
Western blotting (Fig. 2B). Since aP2 is not only expressed in adi-
pocytes but also in macrophages, we performed Western blotting
analysis but did not detect any expression of Gpr116 in the perito-
neal macrophages (data not shown).
3.3. Deletion of Gpr116 in adipose tissue exacerbates glucose
intolerance and insulin resistance in mice
CKO and WT mice were born healthy and at expected Mende-
lian ratios (data not shown), the mice were fed on standard chow
diet (SCD) or high fat diet (HFD) upon weaning and the metabolic
related parameters were monitored. No signiﬁcant differences
were observed in body weight (Fig. 3A) and food intake (Fig. 3B)
between WT and CKO mice, under both SCD and HFD feeding.
However, glucose tolerance test (GTT) showed that deletion of
Gpr116 in adipose tissue caused more severe glucose intolerance
in mice under SCD for 8 wks (Fig. 3C) although the insulin sensitiv-
ity still remains the same as that in WT mice (Fig. 3E). Upon HFD
challenge for 8 weeks, a more pronounced difference on glucose
disposal ability was observed between WT and CKO mice. Speciﬁ-
cally, ablation of Gpr116 in adipose tissue accelerated HFD induced
glucose intolerance (Fig. 3D). Moreover, compared to the WT mice,
CKOmice were more insulin resistant, as determined by the insulin
tolerance test (ITT) (Fig. 3F). To evaluate the glucose stimulated
insulin secretion, serum insulin levels were measured at various
time points post glucose injection. We found serum insulin levels
were lower in CKO mice at early time points compared to the
WT mice on SCD and HFD (Fig. 3G and H), which may be responsi-
ble for the glucose intolerance observed in these mice.
Next, we examined the Akt phosphorylation in liver and skeletal
soleus muscle upon insulin stimulation. Under standard chow
conditions, there is no signiﬁcant difference observed in Akt phos-
phorylation for these two tissues. However, Akt was hypophosph-
orylated in liver and muscle in CKO mice compared to the WT
mice on HFD, indicating that insulin signaling was blunted in liver
and muscle of CKO mice (Fig. 3I). Since increased gluconeogenesis
in liver is one of the major contributors to glucose intolerance,
the extent of liver gluconeogenesis was evaluated by determination
of key genes involved using qRT-PCR. The results demonstrated that
hepatic gluconeogenic genes G6pc and Pck1 were signiﬁcantly
upregulated in CKO mice on HFD feeding (Fig. 3J). Taken together,
the data above indicated that mice with adipose tissue selective
depletion of Gpr116were more susceptible to high fat diet induced
glucose intolerance and insulin resistance which is at least partially
caused by a shift to the preference of hepatic glucose production.
3.4. GPR116 deﬁcient mice exhibit more severe ectopic lipid
accumulation and hyperlipidemia
In order to further deﬁne the physiological consequences from
the deletion of Gpr116 in adipose tissue, phenotypes related to lipid
metabolism were examined and compared inWT and GPR116 deﬁ-
cient mice. We performed oil red O staining to assess the extent of
ectopic lipid accumulation in mice and found that the livers from
CKO mice had a mildly elevated level of lipid accumulation under
SCD (Fig. 4A, upper panel). The difference between WT and CKO
mice was more pronounced in mice fed a HFD (Fig. 4A, lower pa-
nel). Like the observations in liver, skeletal soleus muscles from
WT and CKO mice also had a comparable level of lipid deposition
(Fig. 4B). The lipids in liver and skeletal muscle were also extracted
and quantiﬁed by biochemical assays and the results mirrored the
observations from the oil red O staining (Fig. 4C and D). The genes
related to lipid metabolism were also examined in these two major
metabolic tissues. As shown in Fig. 4E, the mRNA level of the genes
Fig. 1. GPR116 is involved in 3T3-L1 differentiation. (A) Stromal vascular cells and mature adipocytes were isolated from mice epidymal adipose tissue and the levels of
Gpr116 mRNA were examined by qRT-PCR (n = 4). (B) Gpr116 mRNA was examined during differentiation of 3T3-L1 cells. (C) 3T3-L1 preadipocytes were transfected with
scramble-siRNA or Gpr116 speciﬁc siRNA. QRT-PCR analysis of relative mRNA. (D) Oil red O staining of day 8 3T3-L1 cells was performed. (E) Western blotting analysis. (F) The
measurement of triacylglycerol content was done on 24-well plates. (G) Western blotting analysis of GPR116 during differentiation of 3T3-L1 cells. (H) The levels of Gpr116
mRNA in 3T3-L1 preadipocytes treated with Rosiglitazone during differentiation.
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liver of HFD induced obese CKO mice. Similarly, a signiﬁcant de-
crease in these genes was also observed in the skeletal soleus mus-
cle from CKO mice on HFD (Fig. 4F). Furthermore, the mRNA levels
of the lipogenesis genes were also markedly increased in the liver
of HFD fed CKO mice (Fig. 4G).
The lipid proﬁling in circulation was also examined in the WT
and CKO mice. Data showed that plasma concentration of free fatty
acid (Fig. 5A) and TG (Fig. 5B) was modestly higher in CKO miceupon HFD, whereas the serum cholesterol level was largely the
same between the WT and CKO mice (Fig. 5C).
3.5. Deletion of Gpr116 leads to an alteration of adipocyte size and
dysregulation of adipokine expression
Adipose tissue serves as a central commander in glucose and li-
pid metabolism of the body. To further delineate the molecular ba-
sis how GPR116 deﬁciency in adipose tissue causes an impaired
Fig. 3. Deletion of Gpr116 in adipose tissue exacerbates glucose intolerance and
insulin resistance in mice. Body weight (A), Food intake (B) of CKO and WT mice
(n = 10–15). (C–H) GTT of mice on SCD (C), HFD (D), and ITT on SCD (E) and HFD (F)
(n = 7–9), GSIS of mice on SCD (G), HFD (H) (n = 5). (I) Western blotting analysis on
liver and skeletal soleus muscle with the indicated antibodies (n = 3). (J) QRT-PCR
analysis of Pck1 and G6pc mRNA in mouse liver (n = 4). ⁄p < 0.05 compared with WT
mice on HFD.
Fig. 2. Generation and validation of Gpr116 adipose tissue speciﬁc knockout mice.
(A) Strategy for generation of Gpr116 conditional knockout mice. (B) Western
blotting analysis of GPR116 in WAT and lung.
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identify the fundamental changes in adipose physiology per se.
To this end, the epidymal fat pads were isolated and weighed.
We did not observe signiﬁcant difference in the weight of adipose
tissue between the two groups (Fig. 6A). However, when the adi-
pose tissue was subjected to H&E staining, we found the sizes of
the adipocyte in the Gpr116 CKOmice were smaller compared with
those in the WT mice (Fig. 6B and C). The reduction in adipose size
was prominent under both SCD and HFD conditions. In addition,
we found that adipocytes in CKO mice had a slightly decreased
TUNEL staining compared with that in the WT mice (Supplemen-
tary Fig. 2).
The expression of several genes encoding key factors for adipo-
genesis and adipokines in mouse adipose tissue was also examined.
Although most of the genes examined did not show much differ-
ence in expression, the mRNA level of Resistin was strikingly in-
creased in GPR116 deﬁcient adipose tissue under both SCD and
HFD conditions (Fig. 6D). Moreover, the serum level of adiponectin
and resistin was measured by ELISA and the results demonstrated
that CKO mice exhibited a slight but statistically signiﬁcant reduc-
tion of circulating adiponectin and increase of circulating resistin in
comparison to the WT mice (Fig. 6E and F). Besides, there was no
signiﬁcant difference in terms of plasma leptin level between the
control and CKO mice. Insulin resistance is also associated with
inﬂammation that negatively impacts insulin sensitivity.While ser-
um levels of TNF-a and IL-1bwere similar between theWT and CKO
mice on SCD, HFD elevated the secretion of these two proinﬂamma-
tory cytokines in CKOmice thanWTmice (Fig. 6G and H). As shown
in Fig. 6I, expression of inﬂammatory genes such as IL-6, TNF-a,
MCP-1 and IL-1bwas increased in GPR116 deﬁcient adipose tissues
Fig. 4. GPR116 deﬁcient mice exhibit more severe ectopic lipid accumulation and hyperlipidemia. Oil red O staining of liver (A) and muscle (B) cryosections. TG contents in
liver (C) and muscle (D) (n = 5). (E and F) QRT-PCR results of oxidative related gene expression (n = 5). (G) QRT-PCR results of lipogenesis gene expression in liver (n = 5).
⁄p < 0.05 compared with WT mice on HFD.
Fig. 5. Lipid proﬁling in WT and CKO mice. Mice were fasted for 12 h and the concentration of lipids in serum was measured. Plasma FFA (A), triacylglycerol (B), cholesterol
(C), concentrations (n = 9).
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positive macrophages in adipose tissue on HFD (Fig. 6J).4. Discussion
Key factors controlling the function of adipose tissue would rep-
resent potential drug targets for metabolic related diseases. Here
we provide several lines of evidence, both in vitro and in vivo,
demonstrating that GPR116 plays a critical role in adipose tissuefunction. First of all, the expression of Gpr116 was induced during
differentiation of 3T3-L1 preadipocytes. Moreover, siRNA-medi-
ated knockdown of Gpr116 largely inhibited the differentiation
capacity of this cell line. On the other hand, mice with selective
deletion of Gpr116 were more susceptible to high fat diet induced
glucose intolerance and insulin resistance. Furthermore, these
mice were featured by elevated circulating levels of TG, hetatostea-
tosis and smaller adipocytes.
Our in vitro study clearly showed that Gpr116 knockdown
impaired 3T3-L1 preadipocyte differentiation. However, in case of
Fig. 6. Deletion of Gpr116 leads to alteration of adipocyte size and dysregulation of adipokine expression. (A) Weight of the epididymal fat (n = 5). (B) Representative pictures
of H&E staining of epididymal fat sections from CKO and control mice on SCD and HFD. (C) Quantiﬁcation of the adipocyte size. (D) QRT-PCR analysis of adipokines. (E)
Adiponectin plasma values (n = 8). (F) Resistin plasma values (n = 8). (G) TNF-a plasma values (n = 8). (H) IL-1b plasma values (n = 8). (I) QRT-PCR analysis of inﬂammatory
gene expression. (J) F4/80 immunostaining of adipose tissue.
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sue did not differ signiﬁcantly between the WT and CKO mice. Re-
sults from in vitro and in vivo experiments seem inconsistent at
ﬁrst glance: knockdown of Gpr116 inhibited the differentiation of
3T3L1 preadipocytes; whereas in CKO mice, the body weight and
the weight of the fat pad were not signiﬁcantly reduced. However,
the smaller adipocytes in CKO mice might be an indicator of im-
paired adipocyte differentiation, which is, to certain extent, consis-
tent with the in vitro results. Besides, aP2 is expressed relatively
late in adipogenesis and mainly in mature adipocytes. Thus, theknockout mice mainly reﬂected the role of GPR116 in mature
adipocytes.
On the other hand, these observations indicate that acceleration
of aging and high fat diet induced insulin resistance observed in
CKO was caused by a mechanism independent of obesity. Interest-
ingly, similar case is also present in GPR120, another metabolic re-
lated protein in GPCR family. It was reported that downregulation
of GPR120 resulted in inhibition of adipocytes differentiation [10]
whereas GPR120 knockout mice had similar body weight with
the WT mice [15]. It is possible that the unchanged body weight
T. Nie et al. / FEBS Letters 586 (2012) 3618–3625 3625and fat pad are resulted from the redundancy of several GPCRs in
adipogenesis under physiological settings, while under pathologi-
cal conditions; they exert distinct functions in adipose tissue.
Indeed, the TUNEL staining experiment suggested that GPR116
may play a role to render adipocytes more susceptible to pro-
grammed cell death, although the detailed mechanism is currently
unclear.
Several phenotypic differences became more prominent in CKO
mice when the mice were challenged with a high fat diet. This phe-
nomenon suggests that GPR116 might also act to protect the body
from metabolic disorders under pathological conditions, while it is
less involved in maintaining the normal function of the body. In
addition, it is noteworthy that the most consistent changes ob-
served in CKO mice, under both SCD and HFD, were from the adi-
pose tissue, i.e., the smaller adipocytes size, higher resistin and
lower adiponectin level. Hence the smaller adipocytes and abnor-
mal expression of adipokines might represent the primary causes
that in turn evoked the peripheral insulin resistance, hepatic stea-
tosis, hyperlipidemia in CKO mice. It is possible that mice on SCD
would exhibit similar phenotypes to those on HFD upon prolonged
observation.
The circulating level of adiponectin was lowered in CKO mice.
Nevertheless the mRNA level of adiponectin was at a similar level
as the WT mice. Adiponectin is a pleotropic adipokine that pos-
sesses anti-inﬂammatory, anti-atherogenic and insulin-sensitizing
effects [16]. The posttranscriptional maturation of adiponectin,
including assembly and secretion of various forms of adiponectin
oligomers, involves a highly complex but organized machinery.
Therefore, it is intriguing to investigate in the future whether
GPR116 participates in the assembly and secretion of adiponectin.
It should also be noted that due to the high concentration of adipo-
nectin in serum and the complex posttranslational modiﬁcation,
the adiponectin replacement therapy is technically challenging.
Therefore, activation of GPR116 might represent a potential alter-
native to adiponectin replacement therapy.
Our in vivo and ex vivo data have shown that Gpr116 CKO mice
exhibited more pronounced glucose intolerance, elevated systemic
inﬂammation, impaired insulin response in peripheral tissues
including liver and muscle, along with increased gene expression
for the key genes to hepatic gluconeogenesis and lipogenesis. We
hypothesized that abnormal expression and secretion of adipocy-
tokines from adipocytes altered the endocrine functions and
inﬂammation levels in adipose tissues which ultimately caused
uncontrolled whole body glucose metabolism.
Taken together, in the current study, we investigated the role of
GPR116 in adipose biology and systemic energy metabolism.
GPR116 deﬁciency in adipocyte cell lines blocked the full differen-
tiation of adipocytes, which is translated into dysfunctioning adi-
pocytes in vivo, exempliﬁed as smaller size, reduced adiponectin
secretion and upregulated resistin. This study establishes GPR116
as a potential mediator linking adipose tissue dysfunction and sys-
temic insulin resistance. GPR116 is an orphan receptor and the li-
gand for GPR116 is currently unknown. Fatty acids were found to
be ligands for GPR43 and GPR120, the other two GPR proteins that
regulate adipogenesis in 3T3-L1 cells [9–11]. In the case of GPR120,
x-3 fatty acid (x-3 FA) was found to exert insulin-sensitizing ef-
fects when administrated under the HFD conditions [11]. It is per-
ceivable the ligands for GPR116 would regulate insulin resistance
once found. Clearly, identiﬁcation of the natural ligand(s) forGPR116 is important in future works. Meanwhile, our ﬁndings
shed new light on medications that act through rectiﬁcation of adi-
pose tissue dysfunction.
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